PEPTILOGICS
LIVE

Serial Number

50007747

Owner

Peptilogics INC.

Attorney

Elizabeth Lee D'Amore

First Use Date

Jan 6, 2015

Filing Date

Jul 22, 2026

Add to watchlist:

No watchlists yet
View on USPTO

PEPTILOGICS Trademark

Serial Number: 50007747

PEPTILOGICS is a trademark filed by Peptilogics INC. on July 22, 2026. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Peptilogics INC. (2 trademarks)

2681 Sidney Street
Pittsburgh, PA 15203

Entity Type: 03

Trademark Details

Filing Date

July 22, 2026

Registration Date

Not Registered

First Use Anywhere

January 6, 2015

First Use in Commerce

January 6, 2015

Goods & Services

Medical consultancy services relating to drug safety assessment; provision of information relating to the properties of pharmaceutical compounds; consultancy services relating to non-animal-based drug safety testing for regulatory purposes; medical research services in the field of pharmacology and toxicology; medical research services in the field of infectious diseases, antimicrobial therapeutics, and orthopedic infections

Scientific research and development in the field of antimicrobial peptides; research and development of pharmaceutical preparations for the prevention and treatment of infections; research and development relating to peptide discovery, peptide synthesis, and peptide characterization; research and development of anti-infective and anti-biofilm agents; drug discovery services; biotechnology research; biomedical research services; providing temporary use of non-downloadable software for use in artificial intelligence-driven drug discovery, peptide engineering, molecular modeling, pharmaceutical research, therapeutic design, bioinformatics analysis, and computational biology; providing scientific information, analysis, and consulting in the fields of bioinformatics, cheminformatics, computational biology, and peptide therapeutics; Research and development of artificial intelligence and machine learning models for predicting the properties of pharmaceutical compounds; development of in silico platforms for drug safety testing; computational modelling services in the field of pharmacology and toxicology; contract research services in the field of computational drug safety assessment

Filing History

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 24, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Jul 22, 2026 MAFR
NEW APPLICATION ENTERED
Jul 22, 2026 NWAP